��Ѫѹ���˸����������531���ٴ�����

目的探讨高血压病人腹部外科手术前有否控制血压的必要性。方法回顾分析531例行腹部外科手术的高血压病人围手术期病情变化。结果一、二级高血压术前控制血压与否对围手术期病情无显著影响(P>0.05),三级及收缩期高血压术前未控制组围手术期并发症显著高于术前控制组(P<0.05)。结论一、二级高血压术前抗高血压治疗与否不增加手术危险性;三级及收缩期高血压术前应控制血压低于180/110mmHg(24.0/14.7kPa),且宜平稳1～2周,待病情稳定后施行择期手术。     

CT在小肝癌术前定位的作用

目的：总结ＣＴ在小肝癌术前定位中的优越性,提高原发性小肝癌的手术切除率。方法：利用ＣＴ在小肝癌术中的解剖定位作用,确定肿瘤大小、数量、部位与周围脏器及血管关系。结果：５８例肝肿瘤,５７例经ＣＴ解剖定位后切除肿瘤,１例未切除。１５例术中发现肿瘤与血管关系密切,４例为多发病灶。结论：ＣＴ定位准确,能提高手术切除率,在小肝癌的手术中具有重要作用。     

���Σ�ز��˳��ںͳ���Ӫ��֧�ֵ�Ӧ��

目的 研究肠内营养（EN）和肠外营养（PN）支持对外科危重病人的治疗效果。方法 将80例不能进食的研究对象随机分成EN组和PN组,比较营养指标、免疫功能指标、病人耐受性指标的变化。结果在治疗10d后,两组病人均由负氮平衡转为正氮平衡,营养指标及免疫功能指标明显增高,且EN组免疫功能指标增高更显著;病人耐受性指标中,EN组无显著变化而PN组血糖明显增高。结果 EN和PN对外科危重病人均有营养支持和提高机体免疫功能的作用。耐受性强,且EN支持在提高机体免疫功能优于PN支持,病人耐受性较好。     

直肠悬吊术治疗出口梗阻型便秘14例报告

目的：探讨出口梗阻型便秘的手术治疗效果。方法：搜集近年手术治疗的14例出口梗阻型便秘患者的临床资料,分析其病例特点,手术方式及疗效。结果：14例患者中12例（占85、7％）术后一周,症状立即缓解。2例经术后配合功能锻炼3个月症状亦缓解消失。结论：功能性直肠悬吊术,附加盆底疝修补术,盆底抬高,子宫固定,乙状结肠（部分）切除术是治疗出口梗阻型便秘的有效方法。     

Treatment of femoral shaft aseptic nonunion associated with plating failure: emphasis on the situation of screw breakage

BACKGROUND: Femoral shaft aseptic nonunions associated with plating failure resulting from screw breakage are rare, and the treatment is complex and yet to be defined. The aim of this prospective study was to develop a better technique for the treatment of this complication. METHODS: Eight consecutive adult patients who sustained femoral shaft aseptic nonunions associated with plating failure resulting from screw breakage were treated. The procedure involved skeletal traction in the femoral condyle, removal of the broken screws after making a bony window in the lateral cortex, with or without lengthening the femur, stabilization with a static locked nail, and finally, corticocancellous bone grafting. Postoperatively, ambulation with protected weight bearing was encouraged as early as possible. RESULTS: All eight patients were followed up for at least 1 year (range, 1.1-4.7 years), and seven nonunions healed. The median union period was 4 months (range, 3-6 months). One patient had a persistent nonunion, and the locked nail broke at 6 months. The nonunion healed 4 months after closed revision with a new locked nail. CONCLUSION: The described technique has both theoretical and clinical merits. All abnormalities can be corrected concomitantly. The success rate is high and the complication rate is low. Whenever possible, therefore, it may be used to treat all indicated cases of nonunion.     

Angiotensin-converting enzyme inhibition attenuates renal platelet-derived growth factor gene expression and cell proliferation in subtotal nephrectomy

Cell proliferation, matrix accumulation and cell infiltration are characteristic features of progressive glomerulosclerosis and tubulointerstitial fibrosis. Platelet‐derived growth factor (PDGF), a cytokine which has proliferative, prosclerotic and chemokine properties, has been shown to be upregulated in the rat remnant kidney model. Inhibition of the renin–angiotensin system by angiotensin‐converting enzyme (ACE) inhibitors has a beneficial effect on renal function and morphology, but the effect of ACE inhibition on PDGF gene expression and PDGF‐mediated cellular proliferation in subtotal nephrectomy has not been studied in detail. Twelve rats were subtotally nephrectomized (STNx) and received either the ACE inhibitor perindopril or a placebo for 12 weeks. Five sham‐operated rats served as controls. Subtotal nephrectomy was associated with hypertension, proteinuria, elevated plasma creatinine and increased kidney weight. After 12 weeks, PDGF B‐chain mRNA was significantly upregulated in the glomeruli and tubulointerstitium of subtotally nephrectomized rats. ACE inhibition attenuated PDGF mRNA expression in association with a reduction in tubular and glomerular proliferation, as assessed by staining for proliferating cell nuclear antigen. In the context of the known in vitro and in vivo effects of PDGF, it is postulated that the renoprotective action of ACE inhibitors may be partially related to PDGF‐mediated antiproliferative mechanisms.     

Long-term impact of hepatitis B, C virus infection on renal transplantation

Chronic liver disease and its complications are major problems in renal transplant recipients. Our aim was to elucidate the influence of hepatitis B, C virus infection on the long-term outcome of renal transplantation. Four hundred and seventy-seven patients who received renal transplantation between January 1984 and December 1999, and who were followed up at our hospital were enrolled. HBsAg was detected by the RIA method and anti-HCV Ab was assayed by the second-generation RIA kit. SGOT/ SGPT were checked every 3 months. Hepatoma was diagnosed by dynamic CT scan, elevated alpha-fetoprotein, hypervascularity by angiography and confirmed by pathological examination. The prevalence of HBV, HCV, coinfected HBV/HCV was 9.9% (n = 47), 28.5% ( n = 136), 3.1% (n = 15), respectively. The incidences of hepatoma in the HBV-/HCV-, HBV-/HCV+, HBV+/HCV-, HBV+/HCV+ groups were 1.4% (n = 4), 4.4% (n = 6), 6.4% (n = 3), 6.7% (n = 1), respectively (p = 0.114). The incidences of liver cirrhosis/hepatic failure were 3.2% (n = 9), 6.6% (n = 9), 21.3% (n = 10), 20% (n = 3), respectively (p < 0.001). The frequencies of chronic liver disease were 10.4% (n = 29), 45.6% (n = 62), 66% (n = 31), 80% (n = 12), respectively (p < 0.001). Patient and graft survival rates were lower in the HBV-infected group than in the other groups. Cox regression analysis revealed that HBV infection is likely an independent risk factor for patient mortality although the statistical significance was only borderline. Patients with HBV as well as HCV infection were not at risk of graft loss according to this model of analysis. Patients with HBV infection showed higher incidences of hepatoma, hepatic failure, graft failure and death. Therefore, HBV-infected patients who are candidates for renal transplantation should be carefully evaluated. It seems that HCV infection has little influence on the outcome of renal transplant recipients. A longer period of follow-up is needed to clarify the impact of HCV on renal transplant recipients.     

The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men

OBJECTIVE: To evaluate the association of urolithiasis with polymorphic microsatellite (encoding cytosine, adenine, and guanine, CAG) repeats in the exon 1 region of the androgen receptor (AR) gene and thymine/adenine (TA) repeats in the oestrogen receptor (ER). PATIENTS AND METHODS: Patients with urolithiasis (149) and a group of normal controls (102) were examined and compared. The CAG repeats of the AR gene and TA repeats of the ER gene were detected by polymerase chain reaction. The CAG repeats ranged from 171 bp (10 CAG repeats with 141 bp of amplified flanking sequences) to 270 bp (43 CAG repeats). The TA repeats ranged from 160 bp to 194 bp. Associations between calcium oxalate stone disease and the CAG repeats in AR gene and TA repeats in ER gene were then evaluated. The results were classified according to sex and peaks in allelic frequency distribution. RESULTS: There was a significant difference between the male stone patients and the normal controls in the distribution of CAG repeats in the AR gene. Both groups showed a high percentage of 21-repeats in the allelic distribution, at 17 (16%) and 20 (37%) in stone patients and normal controls, respectively. The results indicate that 21-CAG repeats might be related to a lower risk of stone formation in men (P < 0.05). In the ER gene, the peak allelic distribution of TA repeats was 14, showing a significant difference between male stone patients and the normal control subjects (P < 0.01). There were no statistical differences between female stone patients and the control subjects in either the AR or the ER gene. CONCLUSION: Urolithiasis among men appears to be associated with AR gene CAG repeat and ER gene TA repeat polymorphisms, whereas there was no significant association among female stone patients. These sex hormone receptors seem to be related to the higher incidence of stone formation among men.     

Effect of ischaemic preconditioning, cardiopulmonary bypass and myocardial ischaemic/reperfusion on free radical generation in CABG patients.

OBJECTIVE: To investigate the free radicals (FR) generation after ischaemic preconditioning and cardiopulmonary bypass and during reperfusion in CABG patients, and the role of ischaemic preconditioning. METHODS: Forty-three CABG patients were randomised into an ischaemic preconditioning and a control group. The protocol for ischaemic preconditioning was two cycles of 2-min ischaemia followed by 3-min reperfusion. Free radicals were measured using electron spin resonance spectroscopy. Global and right heart functions were collected. RESULTS: The free radicals generation in coronary sinus blood in the ischaemic preconditioning group was 9.7 and 16.6% after the ischaemic preconditioning protocol and 10 min after declamping, 6.8 and 13.3% in the controls. The free radicals in arterial samples were, respectively, 21, 14, 10 and 9% at 10 min, 1, 2 and 24 h after reperfusion. Cardiac index (CI) and right ventricular ejection fraction (RVEF) were improved by ischaemic preconditioning. CONCLUSION: Both ischaemic preconditioning and cardiopulmonary bypass induced free radicals generation. Although ischaemic preconditioning had no effect on free radicals generation after the operation, it protected against postoperative stunning.     

Video-assisted thoracoscopic management of mediastinal tumors.

BACKGROUND: Many successful attempts at removing benign mediastinal tumors with the video-assisted thoracoscopic technique have been reported, but no formal report has been published regarding malignant mediastinal tumors treated with this technique. We report our preliminary experience with video-assisted thoracoscopic removal of mediastinal tumors, benign or malignant. METHODS: Seven patients with mediastinal tumors treated with video-assisted thoracoscopic surgery were reviewed from January 1999 to April 2000. Their tumor pathologies included benign or malignant thymoma, neurilemmoma, and teratoma. RESULTS: The mean operation time was 240 minutes. The mean blood loss was 173 mL. The mean insertion time of chest tubes was 3 days. The mean admission time was 6 days. No deaths occurred during the study. Morbidity occurred in 2 patients. No tumor recurrence has been seen during the mean follow-up of 7 months. CONCLUSIONS: The short-term results support the feasibility of VATS in managing technically resectable mediastinal tumors. Yet the long-term prognosis for the malignant lesions is deferred and needs further study.